跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-SOLIFENACIN SUCCINATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-SOLIFENACIN SUCCINATE
Authorized
STANDARD
M-SOLIFENACIN SUCCINATE
MANTRA PHARMA INC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
ea6a69b158b42280
Company
MANTRA PHARMA INC
Type
Standard
Approval Details
Approval Id
ea6a69b158b42280
Drug Approval Canada Name
M-SOLIFENACIN SUCCINATE
Product Name
M-SOLIFENACIN SUCCINATE
Status
Marketed
Status Date
2023-08-18
Original Market Date
2023-08-18
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
86:12.04
Atc Original
G04BD08 SOLIFENACIN
Aig Number
0151584002
Company Name
MANTRA PHARMA INC
Company Address
1000 Rue Du Lux Suite 201 Brossard Quebec Canada J4Y 0E3
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
ea6a69b158b42280
Type
Standard
Back to Health Canada Approvals